Drugs / DWP09031
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01522586 | Jan 2012 → May 2013 | — | Daewoong Pharmaceutical Co. LTD. | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DWP09031 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01522586 ↗ |
| Route | Oral | “orally administrated DWP09031” NCT01522586 ↗ |